Meribank Biotech Co (ROCO:4724) Interest Expense : NT$-0.8 Mil (TTM As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Meribank Biotech Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Meribank Biotech Co's interest expense for the six months ended in Dec. 2023 was NT$ -0.4 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-0.8 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Meribank Biotech Co's Operating Income for the six months ended in Dec. 2023 was NT$ -63.7 Mil. Meribank Biotech Co's Interest Expense for the six months ended in Dec. 2023 was NT$ -0.4 Mil. Meribank Biotech Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Meribank Biotech Co Interest Expense Historical Data

The historical data trend for Meribank Biotech Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meribank Biotech Co Interest Expense Chart

Meribank Biotech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.55

-0.74

-1.13

-0.99

-0.85

Meribank Biotech Co Semi-Annual Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial							-0.57	-0.47	-0.52	-0.40	-0.45

Meribank Biotech Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-0.8 Mil.

Meribank Biotech Co (ROCO:4724) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Meribank Biotech Co's Interest Expense for the six months ended in Dec. 2023 was NT$-0.4 Mil. Its Operating Income for the six months ended in Dec. 2023 was NT$-63.7 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was NT$14.8 Mil.

Meribank Biotech Co's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Meribank Biotech Co did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Meribank Biotech Co (ROCO:4724) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Meribank Biotech Co Ltd (ROCO:4724) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sector 1, Neihu Road, 1st Floor, No.68, Neihu District, Taipei, TWN, 11493

Website

http://www.meribank.com.tw

Meribank Biotech Co Ltd is engaged in Research and development and sales of new cell drugs and also Umbilical cord blood, placenta and umbilical cord mesenchymal stem cells processing, testing and cryopreservation.

Meribank Biotech Co (ROCO:4724) Headlines

No Headlines